News

News

News

Intellectual Property High Court Decision on the Patent Infringement Lawsuit against Toa Industry Co., Ltd.
March 28, 2024
News

Decision on Non-Acceptance of Appeal Concerning the Patent for 5-Aminolevulinic Acid Phosphate
October 10, 2023
News

Report on Specific Clinical Research Using 5-Aminolevulinic Acid (5-ALA) for COVID-19 Patients
September 5, 2023
News

Judgment on the Patent Infringement Lawsuit against Toa Industry Co., Ltd.
July 28, 2023
News

Launch of “WIZALA (WithALA),” a Supplement for Adult Dogs and Cats
May 1, 2023
News

Judgment on the Patent Revocation Lawsuit Regarding the 5-Aminolevulinic Acid Phosphate Patent
March 22, 2023
News

Launch of “ALAVITAL (AraVital),” a Supplement Containing 5-ALA
March 14, 2023
News

Publication of a Paper on the Improvement of Glucose Tolerance in Mitochondrial Diabetes by 5-Aminolevulinic Acid (5-ALA)
December 9, 2022
News

Launch of “WIZALA (WithALA),” a Supplement for Puppies and Kittens
October 13, 2022
News

Announcement of Anti-Doping Certification for 5-Aminolevulinic Acid (5-ALA) Raw Materials
August 30, 2022

KIYAN PHARMA Co., Ltd.

Contact Information

6-2-6 Kojimachi, Chiyoda-ku, Tokyo 102-0083, PMO Kojimachi 8th floor

Mail：info@kiyan.jp

Contact UsContact Us